SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-20-000151
Filing Date
2020-09-09
Accepted
2020-09-09 16:17:51
Documents
16
Period of Report
2020-09-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20200904.htm   iXBRL 8-K 53602
2 EX-99.1 stockconnecten49-4x202.htm EX-99.1 11797
3 EX-99.2 canadanda-ex992.htm EX-99.2 40684
  Complete submission text file 0001651308-20-000151.txt   303643

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20200904.xsd EX-101.SCH 2505
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20200904_cal.xml EX-101.CAL 793
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20200904_def.xml EX-101.DEF 8592
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20200904_lab.xml EX-101.LAB 30141
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20200904_pre.xml EX-101.PRE 21942
9 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20200904_htm.xml XML 11830
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 201166709
SIC: 2834 Pharmaceutical Preparations